Uniphar Group PLC (IR:UPR) — Market Cap & Net Worth
Market Cap & Net Worth: Uniphar Group PLC (UPR)
Uniphar Group PLC (IR:UPR) has a market capitalization of $951.34 Million (€813.73 Million) as of September 17, 2026. Listed on the IR stock exchange, this Ireland-based company holds position #9116 globally and #10 in its home market, demonstrating a -3.47% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Uniphar Group PLC's stock price €4.03 by its total outstanding shares 259574298 (259.57 Million). Also see total assets of Uniphar Group PLC for a full breakdown of the balance sheet.
Uniphar Group PLC Market Cap History: 2019 to 2026
Uniphar Group PLC's market capitalization history from 2019 to 2026. Data shows growth from $362.83 Million to $1.22 Billion (19.20% CAGR). Also see cash efficiency ratio of Uniphar Group PLC for how efficiently the company converts equity into cash flow.
Index Memberships
Uniphar Group PLC is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ISEQ 20 Price
IETP
|
$97.83 Billion | 0.97% | #9 of 19 |
|
ISEQ Overall
ISEQ
|
$99.32 Billion | 0.96% | #10 of 31 |
Weight: Uniphar Group PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Uniphar Group PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Uniphar Group PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check UPR share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.23x
Uniphar Group PLC's market cap is 0.23 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.02x
Uniphar Group PLC's market cap is 10.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $362.83 Million | $1.67 Billion | $21.03 Million | 0.22x | 17.26x |
| 2020 | $711.45 Million | $1.82 Billion | $27.83 Million | 0.39x | 25.57x |
| 2021 | $1.50 Billion | $1.94 Billion | $48.08 Million | 0.77x | 31.29x |
| 2022 | $937.11 Million | $2.07 Billion | $45.59 Million | 0.45x | 20.56x |
| 2023 | $819.37 Million | $2.55 Billion | $44.81 Million | 0.32x | 18.28x |
| 2024 | $643.36 Million | $2.77 Billion | $64.20 Million | 0.23x | 10.02x |
Competitor Companies of UPR by Market Capitalization
Companies near Uniphar Group PLC in the global market cap rankings as of September 17, 2026. Review tangible equity quality of Uniphar Group PLC to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Uniphar Group PLC by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #249 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #541 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #642 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1204 globally with a market cap of $21.56 Billion USD ( AU$30.48 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #249 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $899.56 |
| #541 | Cencora Inc. | NYSE:COR | $50.53 Billion | $323.29 |
| #642 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $232.65 |
| #1204 | Sigma Healthcare Ltd | AU:SIG | $21.56 Billion | AU$2.64 |
Uniphar Group PLC Historical Marketcap From 2019 to 2026
Between 2019 and today, Uniphar Group PLC's market cap moved from $362.83 Million to $ 1.22 Billion, with a yearly change of 19.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.22 Billion | +14.49% |
| 2025 | €1.07 Billion | +66.04% |
| 2024 | €643.36 Million | -21.48% |
| 2023 | €819.37 Million | -12.56% |
| 2022 | €937.11 Million | -37.71% |
| 2021 | €1.50 Billion | +111.47% |
| 2020 | €711.45 Million | +96.09% |
| 2019 | €362.83 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Uniphar Group PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $951.34 Million USD |
| MoneyControl | $951.34 Million USD |
| MarketWatch | $951.34 Million USD |
| marketcap.company | $951.34 Million USD |
| Reuters | $951.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Uniphar Group PLC
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers;… Read more